Healthy Extracts (HYEX) Current Assets (2015 - 2025)
Healthy Extracts' (HYEX) quarterly Current Assets came in at $1.3 million in Q4 2025, down 20.01% year-on-year from $1.7 million in Q4 2024, and down 23.21% quarter-over-quarter from $1.7 million in Q3 2025.
Healthy Extracts (HYEX) Current Assets (2015 - 2025) Analysis & Trends
Healthy Extracts' Current Assets history runs 11 years deep, the most recent figure standing at $1.3 million for Q4 2025.
- On a quarterly basis, Current Assets fell 20.01% year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $1.3 million, a 20.01% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 20.01% from the prior year.
- Current Assets fell to $1.3 million in Q4 2025 per HYEX's latest filing, from $1.7 million in the prior quarter.
- Across five years, Current Assets topped out at $2.9 million in Q2 2021 and bottomed at $1.3 million in Q4 2025.
- The 5-year median for Current Assets is $1.9 million (2023), against an average of $2.0 million.
- Across the five-year window, Current Assets decreased 29.53% in 2021 and decreased 0.22% in 2025, its largest moves.
- Year by year, Current Assets stood at $2.3 million in 2021, then slipped by 11.66% to $2.0 million in 2022, then retreated by 7.04% to $1.9 million in 2023, then retreated by 12.65% to $1.7 million in 2024, then declined by 20.01% to $1.3 million in 2025.
- Per Business Quant, the three latest HYEX Current Assets figures stand at $1.3 million (Q4 2025), $1.7 million (Q3 2025), and $1.6 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | 1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | 1.56 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 1.75 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 1.90 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | 2.13 Mn |
| Mar 31, 2022 | 2.21 Mn |
| Dec 31, 2021 | 2.31 Mn |
| Sep 30, 2021 | 2.73 Mn |
| Jun 30, 2021 | 2.91 Mn |
| Mar 31, 2021 | 2.74 Mn |